Saltar para: Post [1], Pesquisa e Arquivos [2]
Cada um cumpre o destino que lhe cumpre. / E deseja o destino que deseja; / Nem cumpre o que deseja, / Nem deseja o que cumpre. [Ricardo Reis]
Outros documentos, sites e organizações com informações úteis e interessantes.
Generics are seen as important products in the context of promoting the rational use of medicines. Two key measures for promoting generic use are international non-proprietary name (INN) prescribing and generic substitution.
Survey on rational use of medicines in 27 EU Members States
Measures for promoting the rational use of medicines in the 27 EU Member States were surveyed in a report by the Gesundheit Österreich GmbH / Österreichisches Bundesinstitut für Gesundheitswesen (GÖG/ÖBIG – Austrian Health Institute) [Rational Uses of Medicines in Europe].
Their results showed that there are many different practices between the different Member States in the EU with regard to generic medicine policies. An overview is given in the table below:
For example, while most countries (22) advocate international non-proprietary name (INN) prescribing, relatively few (4) have made this obligatory, whereas generic substitution by the pharmacist is practiced in the majority of countries (21).
Some important details about "INN groups”
Other relevant information can be found in the aforementioned note (DOC, 130 Kb). Clarification (PDF, 21.37 Kb) of some points of the note. List (PDF, 75.46 Kb) of authorised and marketed biological medicines.
Nota: Todos os sublinhados são da minha responsabilidade.
A subscrição é anónima e gera, no máximo, um e-mail por dia.